Recurrence free survival was shorter and metastatic events higher among women with ERα—positive tumors that have increased expression of mRNA for Rac3, while the expression of the mRNA for Rac3 does not correlate with metastasis in ERα—negative tumor samples. Here, RAC3 is linked to neoplasm.